Equities research analysts at Wells Fargo & Co. (NYSE: WFC) started coverage on shares of Cerner Corp (NASDAQ: CERN) in a research note issued to investors on Wednesday. The firm set a “market perform” rating on the stock.
Several other analysts have also recently commented on the stock. Analysts at Lazard Capital initiated coverage on shares of Cerner Corp in a research note to investors on Wednesday, May 23rd. They set a “buy” rating on the stock. Separately, analysts at Zacks reiterated an “outperform” rating on shares of Cerner Corp in a research note to investors on Monday, April 30th. They now have a $93.00 price target on the stock. Finally, analysts at Raymond James (NYSE: RJF) upgraded shares of Cerner Corp from a “market perform” rating to an “outperform” rating in a research note to investors on Monday, April 30th.
Shares of Cerner Corp traded down 1.83% during mid-day trading on Wednesday, hitting $78.24. Cerner Corp has a one year low of $53.93 and a one year high of $79.82. The company has a market cap of $13.336 billion and a P/E ratio of 41.95.
Cerner Corp last issued its quarterly earnings data on Thursday, April 26th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.04. The company’s revenue for the quarter was up 30.4% on a year-over-year basis. On average, analysts predict that Cerner Corp will post $0.59 earnings per share next quarter.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HIT) solutions, healthcare devices and related services.